CARASIL with coronary artery disease and distinct cerebral microhemorrhage: A case report and literature review. Issue 1 (24th March 2020)

• Record Type: Journal Article
• Authors: Müller, Sebastian J; Khadhraoui, Eya; Allam, Ibrahim; Argyriou, Loukas; Hehr, Ute; Liman, Jan; Hasenfuß, Gerd; Bähr, Mathias; Riedel, Christian H; Koch, Jan C
• Is Part Of: Clinical and translational neuroscience. Volume 4:Issue 1(2020)
• Publication Date: 2020-03-24
• Subjects: CARASIL -- Maeda syndrome -- small cerebral vessel disease -- NSTEMI -- HTRA1; Neurosciences -- Periodicals; Psychiatry -- Periodicals; Nervous system -- Diseases -- Periodicals; Psychotherapy -- Periodicals; 616.8005
• DOI: 10.1177/2514183X20914182
• Languages: English
• ISSNs: 2514-183X

Abstract

Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL, Maeda syndrome) is an extremely rare autosomal-recessive genetic disorder with a serious arteriopathy causing subcortical infarcts and leukoencephalopathy. In less than 20 cases, a genetic mutation was proven. Patients suffer from alopecia, disc herniations, and spondylosis. Between the age of 30 and 40, the patients typically develop severe cerebral infarcts. Clinical symptoms, genetic study, magnetic resonance imaging (MRI), and coronary angiography of a patient with proven CARASIL are presented. The patient showed the typical phenotype with cerebral small-vessel disease, cerebral infarcts, spondylosis, and abnormal hair loss. Additionally, distinct cerebral microhemorrhage and a severe coronary artery disease (CAD) were found, which have not been reported before for CARASIL. Mutation screening revealed the presence of a homozygous c.1022G > T substitution in the HTRA1 gene. Evidence from other publications supports a pathogenetic link between the HTRA1 mutation and CAD as a new feature of CARASIL. This is the first report about CARASIL with a concomitant severe CAD. Thus, in patients with CARASIL, other vessel diseases should also be considered.